<!DOCTYPE html>
<html lang="en">
    <head>
        <title>displaCy</title>
    </head>

    <body style="font-size: 16px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol'; padding: 4rem 2rem; direction: ltr">
<figure style="margin-bottom: 6rem">
<div class="entities" style="line-height: 2.5; direction: ltr"></br> ==== Front</br> J Transl MedJ Transl MedJournal of Translational Medicine1479-5876BioMed Central London 197110.1186/s12967-019-1971-7ReviewSmoking and microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oral, airway, gut and some systemic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Huang Chunrong huangchr5@mail2.sysu.edu.cn 12Shi Guochao shiguochao@hotmail.com 121 0000 0004 0368 8293grid.16821.3cDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197, Rui Jin Er Road, Shanghai, 200025 People’s Republic of China 2 0000 0004 0368 8293grid.16821.3cInstitute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, 197, Rui Jin Er Road, Shanghai, 200025 People’s Republic of China 15 7 2019 15 7 2019 2019 17 22517 3 2019 5 7 2019 © The Author(s) 2019Open 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AccessThis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.The human microbiome harbors a diverse array of microbes which establishes a mutually beneficial relation with the host in healthy conditions, however, the dynamic homeostasis is influenced by both host and environmental factors. Smoking contributes to modifications of the oral, lung and gut microbiome, leading to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    various diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, asthma, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic obstructive pulmonary disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and cancers. However, the exact causal relationship between smoking and microbiome alteration remains to be further explored.</br> </br> Keywords</br> MicrobiomeOralLungGutDiseasehttp://dx.doi.org/10.13039/501100001809National Natural Science Foundation of China81770025Shi Guochao issue-copyright-statement© The Author(s) 2019</br> ==== Body</br> Background</br> Approximately 2 billion people worldwide use tobacco products, mostly in the form of cigarettes, with tobacco 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smoking-related diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 resulting in at least 4 million global deaths per year [1]. Dramatic rise of diseases associated with cigarette smoke or tobacco use, including 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cardiovascular disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic obstructive pulmonary diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
), 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and various forms of cancer [2], implying the potential detrimental role of smoking in occurrence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    human diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Emerging evidence suggests that environmental factors play an influential role in shaping human-associated microbial communities and immune responses. Either active smoking or exposure to secondhand smoke is associated with colonization by potentially 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenic bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [3–5]. Yet, in an era where microbes not only cause acute 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infectious
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 illnesses but also are increasingly being recognized as etiologic agents or risk factors for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 including cancers [6–8] and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    neurologic disorders
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [9, 10], it is important to have a profound understanding of the effect of smoking on microbiome in diseases.</br> </br> The microbiome refers to a community of microbes residing in a defined environment, comprising of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    viruses
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and protozoa, together with their genes and genomes in a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    given locus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. The gastrointestinal microbiome is the most complex echo-system of 10–100 trillion 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    microorganisms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, in which the amount of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 was the most, in the next place was that of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    virus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [11]. The oral communities come as the second in the human body [12]. With the initiation of the Human Microbiome Project in 2007, the use of culture-independent methods allied with next generation DNA sequencing methods to identify the composition of the human microbiome, is providing a far deeper analysis than hitherto possible [13], including 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 ribosomalRNA (rRNA) sequencing, metagenomic sequencing, and microbial metatranscriptomics [14]. The once called sterile lung based on conventional culture methods was unraveled to contain variable microbiomes depending on health and specific disease states [15, 16]. The human microbiome has the stability and resilience to restore themselves after perturbation maintains homeostasis in health, but its composition is susceptible to many factors such as antibiotics, diet, alcohol, and smoking [17] (Table 1). It has become clear that the microbiome is not a passive victim in many pathological processes, but its modification often play a contributive or causative role in pathophysiological processes [18]. Thus far, most studies have described the microbial composition of healthy or diseased organs, and smoking associated alterations of microbiome in different sites were demonstrated in a variety of diseases (Table 2). In this review, we will summarize the current understanding of the impact of smoking on microbiome and its involvement in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    various diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and thereby highlighting important research questions that require further investigation.Table 1 Alterations of microbiome in healthy smokers</br> </br> 	Reference	Origin	Sample	Enriched microbes	Depleted microbes	</br> Oral	[37]	Human	Subgingival plaque	Species: Fusobacterium nucleatum, F. naviforme, Filifactor alocis, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Dialister microaerophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Desulfobulbus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 sp. clone 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    R004
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Megasphaera sueciensis, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    M. geminatus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, M. elsdenii, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    M. micronuciformis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Acinetobacter johnsonii, A. guillouiae, A. schindleri, A. baumannii, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    A. haemolyticus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Pseudomonas pseudoalcaligenes, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Pseudoramibacter alactolyticus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
	Species: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 sanguinis, S. parasanguinis, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S. oralis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Granulicatella elegans, G. adiacens, Actinomyces viscosus, A. israelii, A. dentalis, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 subflava, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Hemophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 parainfluenzae	</br> [191]	Human	Oral wash samples	Genera: Atopobium, Bifidobacterium, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lactobacillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
		</br> [192]	Human	Mouth wash sample	Phylum: Spirochaetes, Synergistetes and Tenericutes, Bacteroidetes and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Genera
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: Treponema, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TG5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and Mycoplasma, Megasphaera, Dialister, Paludibacter, Porphyromonas, Prevotella, Atopobium</br> </br> 	Phylum: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Fusobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SR1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GN02
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Cyanobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Genera: Neisseria, Eikenella, Aggregatibacter, Actinobacillus, Haemophilus, Lautropia, Fusobacterium, Leptotrichia
 
 	
 Airway	[
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
193]	Human	Nasopharyngeal swab, oropharyngeal swabs	Oropharynx</br> </br> Genera: Megasphaera, Veillonella spp.</br> </br> Nasopharynx</br> </br> Genera: Eggerthella, Erysipelotrichaceae I.S., Dorea, Anaerovorax, Eubacterium spp.</br> </br> 	Oropharynx</br> </br> Genera: Capnocytophaga, Fusobacterium, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp.</br> </br> Nasopharynx</br> </br> Genera: Shigella spp.</br> </br> 	</br> [194]	Mice	Lung sample	Genera: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Trichococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Escherichia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
–Shigella, Oxalobacteraceae	Genera: Oceanospirillales, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lactobacillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Lactobacillaceae, Enterobacter, Acidimicrobiales_norank, Caulobacteraceae_ Phyllobacteriaceae_uncultured, Raoultella, Caulobacteraceae_unclassified	</br> [88]	Human	
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BALF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
	Virome: Prevotella, Xanthomonas, Actinomyces, Aeromonas, Capnocytophaga, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Haemophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and Rhodoferax phages	Virome: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lactobacillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Gardnerella phages, Enhydrobacter, Enterobacter, Holospora, Morganella, Enhydrobacter, and Spiroplasma phages	</br> Gut	[124]	Rat	Caecal contents	Not reported	Genera: Bifidobacterium sp.	</br> [125]	Mice	Caecal contents	Genera: Clostridium sp.	Genera: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lactococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 sp., 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ruminococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 sp., Enterobacteriaceae sp. and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    segmented filamentous bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
	</br> [175]	Mice	Colonic sample	Genera: Lachnospiraceae sp.	Not reported	</br> </br> Table 2 Influence of smoking on the microbiome in some diseases</br> </br> Diseases	Reference	Origin	Sample	Enriched microbes	Depleted microbes	</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
	[60]	Human	Subgingival plaque sample	Genera: Fusobacterium, Fretibacterium, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Veillonella, Corynebacterium, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TM7
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Filifactor	Genera: Prevotella, Campylobacter, Aggregatibacter, Veillonellaceae 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GQ422718
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Haemophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Prevotellaceae	</br> Asthma	[104]	Human	Subgingival plaque sample	Genera: Fusobacterium, Prevotella and Selenomonas	Not 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reported	
 Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
	[128]	Human	Subgingival plaque sample	Genera: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Anaeroglobus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bulleidia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Corynebacterium, Granulicatella	Genera: Veillonella, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TM7
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
	</br> </br> </br> Possible mechanism of the impact of smoking on microbiome</br> Massive studies demonstrated the adverse health impacts of tobacco on systemic pathophysiologic changes that can lead to disease, were associated with the chemicals, heavy metals, particulate matter and other constituents in tobacco [19–27]. However, a paucity of studies investigated the microbes in tobacco recent years, and this may be incriminated as causative factors in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smoking-associated diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Before advances in DNA sequencing technology, the golden standard of identification of microbes-culture method, was used to identify the Pantoea agglomerans, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Acinetobacter calcoaceticus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and specific Pseudomonadaceae species such as P. fluorescens and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Stenotrophomonas maltophilia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in fresh tobacco leaves or other species in single tobacco flakes or fine tobacco particles [24, 26]. With the advent of high-throughput sequencing technology, a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 rRNA-based taxonomic microarray and cloning and sequencing were utilized to identify a variety of uncultured species. Cigarettes made in the European Union contained 15 different classes of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Sapkota et al. revealed extensive bacterial diversity in cigarettes, ranging from 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    soil microorganisms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and commensals to potential human pathogens, including Acinetobacter, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bacillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Burkholderia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Clostridium, Klebsiella, and Pseudomonas aeruginosa. Many of the detected organisms are capable of causing 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteremias
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, foodborne illnesses, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    meningitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    urinary tract infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [28]. Therefore, mechanism that may lead to different 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 profiles among smokers may be due to exposure to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in cigarettes, leading to bacterial acquisition and colonization.</br> </br> Another possibility for the mechanism through which current smokers may have different 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 community may be related to impaired antimicrobial defenses due to the immunosuppressive nature of tobacco. Tobacco smoking has been observed to affect the peripheral immune system on several levels, including a decrease in the activity of natural killer cells, increase in white blood cell counts, and a higher susceptibility to infection [29]. Smoking increases the number of macrophages, neutrophils, eosinophils, and mast cells, decreases the number of airway dendritic cells, and alters macrophage and neutrophil function [30, 31]. Expanding macrophages and neutrophils demonstrated impaired phagocytic functions to the efficient clearance of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 or pathogen, as evidenced by reduced bacterial-stimulated production of superoxide and surface receptor expression, (e.g. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TLR2
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) which is important for the recognition and response to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gram-positive bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [32, 33]. Therefore, smoking related immunosuppression could permit novel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 colonization.</br> </br> It is also possible that metabolic advantages of biofilm formation and increased adherence to the epithelium are conferred to certain taxa expansion in a smoky environment. Exposure to cigarette smoke could increase biofilm formation by 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    specific bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [34, 35]. Biofilm is a self-generated polymer matrix that insulates the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pneumococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and other microbial pathogens from host defense and antibiotics, promoting bacterial persistence [36]. Mutepe et al. found that increased biofilm formation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 pneumoniae and inactivation of pneumolysin induced by exposure to cigarette smoke condensate are likely to favor microbial colonization and persistence, both being essential precursors of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pneumococcal disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [35]. Similarly, in another study, observations of increased biofilm formation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Staphylococcus aureus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and human cell adherence in the presence of cigarette smoke (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) indicate the role of bioactive effects of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 on resident microbiota in the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    respiratory infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-exposed humans [34]. These findings suggest that cigarette smoke may promote colonization and persistence of specific bacterial taxa in the human body through the biofilm formation, contributing to infections in different parts of the body.</br> </br> “Microenvironment” may also be relevant regarding the influence of smoking on particular members of the microbiota, such as oxygen, pH, and acid production. Oxygen tension is an important promoter of the changes in bacterial community, with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    microaerophilic and anaerobic bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 able to predominate due to lower oxygenation [37, 38]. Shanahan et al. demonstrated a reduction of the relative abundance Prevotella and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp. and an increased relative abundance of Firmicutes, principally 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp., and Veillonella spp., along with the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    genus Rothia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) in the upper 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GI
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 tract from current smokers, compared with that from persons who have never smoked [39]. The differences observed in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Rothia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp. in current smokers indicated the implication of changes in oxygen tension. In that study, alterations in duodenal bicarbonate secretion [40] and lower pH [41] in smokers may also provide selective pressure on the growth of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, which is one of the capnophiles and sensitive to acid conditions [42], whereas 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Rothia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp. are acidogenic and acid tolerant.</br> </br> According to above discussion, we could reach the conclusion of mechanisms of cigarette smoking to influence the microbiome via changes to immune homeostasis, biofilm formation, oxygen tension, or through direct contact with microbes it contained, and these mechanisms may be involved in the occurence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    various diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (Fig. 1).Fig. 1 Schematic summary illustrating the possible mechanisms of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smoking-induced dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of microbiome and its possible role in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    different diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> </br> </br> Smoking and oral microbiome in diseases</br> The oral microbiome, comprising more than 2000 bacterial species [43], plays an important role in the maintenance of oral health [44]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of oral microbiota has been associated locally with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontal, respiratory, cardiovascular and systemic cancers
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, including 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    head and neck cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [45], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pancreatic cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [46], and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    esophageal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [47], yet regarding factors that influence the oral microbiome composition are poorly understood. Smoking is a major environmental factor that influences orodental pathophysiology [48]. Toxic components and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in cigarette impact 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oral bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 directly or indirectly through immunosuppression, oxygen deprivation, biofilm formation, or other potential mechanisms [49], leading to loss of beneficial oral species and pathogen colonization, ultimately to disease [50]. Despite of different sampling sites or laboratory methodologies, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    numerous
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 studies have shown 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    predominant or inhibited genera
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in oral from smokers compared with non-smokers. Culture results of smokers showed less 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    numerous
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 species or Branhamella [51, 52]. Due to limitations on bacterial profiling of traditional method, recently, sequence analysis of bacterial 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 rRNA-encoding genes was performed to identify the different mouth communities between nonsmokers and smokers in species such as Porphyromonas, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and Gemella [53]. Mason et al. revealed the microbial profiles of subgingival plaque samples from 200 systemically and periodontally healthy smokers and never-smokers were different at all taxonomic levels, and principal coordinate analysis revealed distinct clustering of the microbial communities based on smoking status. Smokers demonstrated a highly diverse, pathogen-rich, commensal-poor, anaerobic microbiome that is more closely aligned with a disease-associated community in clinically healthy individuals, suggesting that it creates an at-risk-for-harm environment that is primed for a future ecological catastrophe [37].</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> Evidences indicate that 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 was associated with smoking and complex microbial communities in the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    subgingival sulcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [54–56], and cigarette smokers were found to have a statistically significant higher risk of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    severe periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 than non-tobacco users [57]. More and more researchers focused on the associations between smoking and sub-gingival bacterial species in the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Smoking-associated periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is less diverse and distinct from that of non-smokers. Shchipkova et al. explored that the microbial profile of smokers with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    moderate to severe chronic periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and demonstrated significant differences in the prevalence and abundance of disease-associated and health-compatible organisms, with greater abundance of Parvimonas, Fusobacterium, Campylobacter, Bacteroides, and Treponema and lower levels of Veillonella, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [58]. The differences existed in the composition of the subgingival microbiome between smoker and non-smoker patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic moderate periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 were also elucidated in other studies [59–61]. In addition, smokers are at high risk for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    other oral diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, such as peri-implant mucositis and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    peri-implantitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [62, 63]. Tsigarida et al. demonstrated smoking shapes the peri-implant microbiome of peri-implant biofilm samples from patients with peri-implant health, peri-implant mucositis, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    peri-implantitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [63], paralleled with studies depicting that the underlying mechanism is through depleting commensals from this niche and favoring colonization of pathogens [63].</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Infective endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> In recent years, significant associations have been elucidated between 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    other systemic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [64, 65], and the bacterial flora of the mouth entering the bloodstream may potentially be involved in the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    invasive infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infective endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and the bacterial flora of the mouth entering the bloodstream may potentially be involved in the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    invasive infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infective endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [66]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Oral bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients have been reported to be shown different community compositions from that of healthy individuals [67, 68]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Staphylococcus aureus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, viri-dans Streptococci and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Enterococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp. are the most common pathogens identified [69]. Gemella sanguine, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus tigurinus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, L. goodfellowi were also found to be the cause of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infective endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [70–72]. However, there was barely study about the effect of smoking on 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infective endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 regarding oral microbiome. Biofilm formation, complex mechanisms with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    other bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 might play a crucial role in the occurrence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    invasive infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [71]. Indeed, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is also considered an example of a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biofilm-mediated disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [73]. Given the importance of biofilm formation for adhesion in the oral cavity [70], and the fact that cigarette smoke increased biofilm formation by 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    specific bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and promoted colonization [34], it would be reasonable to suspect that oral microbiome might be the missed connectivity between smoking and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infective endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Further studies on whether smoking could increase the incidence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    infectious endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 through altering oral micro-organisms remains to be elucidated.</br> </br> Other</br> In addition to local health, oral microbiome also plays an important role in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    other systemic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, including 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 infection, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gastrointestinal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, even 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    immune diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 infection has been associated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of oral microbiome, with increased levels of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenic bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [74, 75], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-infected smokers showed rich abundance of specific bacterial taxa compared to infected non-smokers, including Granulicatella, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lactobacillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Veillonella, Enhydrobacter, Streptococcaceae and Comamonadaceae, moreover, abundance of the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungal genus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Candida was also increased in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-infected smokers [76]. Oral microbiome was also corroborated to be associated etiologically with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gastrointestinal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in virtue of composition concordance among sites within the oral cavity and gut, and anatomical acquirement of gut microbiome from mouth. In 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 participants, current smoking was associated with a 33% decrease in relative counts of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Betaproteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (primarily 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Neisseria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) and 23% increase in relative abundance of Veillonellaceae family [77]. These data indicated that community composition of oral microbiome may be associated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    numerous diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, cancer, and diabetes, however, it remains to elucidate the causative relationship between a specific bacterium and the disease, and future work may also wish to consider this potential association.</br> </br> Smoking and airway microbiome</br> Because of the presence of a sparse microbiome, especially in healthy conditions, traditional standard microbiological culture-based methods can hardly detect microbes in healthy individuals, so the lung has historically been presumed as sterile. Over the past several years, culture-independent molecular methods springing up, lung microbial communities in healthy individuals showed a phenotype predominant by 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Firmicutes and Bacteroidetes, as evidenced by bronchoalveolar lavage samples of healthy adults, bacterial communities vary with different airways in terms of different airway microarchitecture, and documented changes in the lung microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    several lung diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 have been uncovered [78, 79].</br> </br> Smoking, cigarette smoke exposure, tobacco smoke or pollutants in the air contact directly with the airway, through the way to the lungs, causing a variety of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    airway diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, asthma, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lung cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. In recent years, the effect of smoking on microbiome of lower respiratory tract attracted increasing attention. Mammen and Aethi proposed a revised “
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Vicious
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Circle”, suggesting that insults such as tobacco smoke impairs innate immune defenses, causing variations in the abundance, taxonomic composition and phylogenetic diversity of the lung microbiome. This, in turn, leads to maladaptive inflammatory responses, further impairment of lung defenses and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    further dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of the lung microbiome, setting up the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    vicious
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 circle with its attendant consequences [80].</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic airway inflammatory disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 that can be prevented and treated 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lung disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, characterized by a largely irreversible chronic obstruction of airflow. The course of the disease is featured and frequently aggravated by intermittent exacerbations, acute changes in the airway microbiome, for example by introduction of a new strain of a respiratory pathogen, lead to larger inflammatory responses, which present clinically as exacerbations of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [80], so changes in the composition and activity of the microbiome may be implicated in their appearances. Pragman et al., once described the lung microbiome in moderate and severe 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients, with the former dominated by 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, the later by 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and Firmicutes, and they also found a trend without significant difference that severe subjects contained more Firmicutes and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    less Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 than the moderate subjects [81]. However, in another cohort study, in both stable and exacerbated samples, the most prevalent phyla were 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Firmicutes and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, the most 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    prevalent genera
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 were 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Haemophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, exceeding half of the abundance of present bacterial microbiome [82]. Although these researchers also found no significant differences in bronchial microbiome between stability and exacerbation using 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 rRNA sequencing and shotgun metagenomic sequencing, functional metabolic capabilities showed significant changes in several pathways, indicating specific changes in the lung microbiome in the progression of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [82].</br> </br> Smoking is the principal cause or initiating factor responsible for the development of the disease in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients. It alters host–
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    microorganism
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 interaction dynamics in the airways, contributing to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [83]. The influence of cigarette smoke on the microbiome and the role of the microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 are relatively new field with limited data. Erb-Downward et al. showed the diversity of bacterial communities in bronchoalveolar lavage fluid (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BALF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) from healthy smokers was similar to that from healthy never-smokers, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients, however, further results from obtained lung tissues of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients unraveled the heterogeneity and diversity in the bacterial microbiota across different regions of the abnormal lung [79], suggesting specific changes in lung microbiome resulted from smoking in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients participate in the occurrence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 or exacerbation. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Respiratory tract infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, either viral or bacterial, are major causes of acute exacerbation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AECOPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) [84]. Cigarette smoke exposure is a well-known risk factor for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    important bacterial and viral infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in the respiratory tract [85]. In the lung ecosystem, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    virus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 also plays a pivotal roles in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lung diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, for example, phages could lead to immune-mediated microbial competition [86], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    opportunistic infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [87], therefore, alterations of lung viral communities could change the bacteriome leading to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and disease progression in individuals (e.g., 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
). Gregory et al. performed the first study of the effects of smoking on the lung DNA virome, lung viromes profiles were statistically indistinguishable across smokers and nonsmokers, and viral diversity was significantly lower in the lungs of healthy smokers [88]. Statistical analyses revealed that changes in viral communities correlate most with changes in levels of arachidonic acid and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IL-8
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, both potentially relevant for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [88]. These data imply the potential role of changes in viral communities induced by smoking in the development of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Although the role of smoking on microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 needs to be further investigated, early studies have suggested an association between lung microbiota and the clinical outcomes of disease.</br> </br> Asthma</br> Asthma is a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic airway inflammatory disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, characterized by reversible airway obstruction, chronic airway inflammation, and airway hyper-responsiveness [89–91]. There are an emerging number of studies shown the correlations between airway microbiome and the incidence, severity or reactivity of corticosteroid medications of asthma [92–95]. Asthmatic patients harbored higher abundance of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and lower Bacteroidetes phylum compared to healthy control as evidenced from samples of bronchial epithelial brushings [96], and the sputum microbiota in severe asthma patients differs from healthy controls and non-severe asthmatics, with a significant correlation between 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp. and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eosinophilia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in severe asthma patients [94]. Airway colonization with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    distinct specific bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 were also associated with the severity of airways obstruction, neutrophilic airway inflammation [97] and corticosteroid resistance in asthma [98]. While the bacterial communities in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    airway inflammatory disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 have been extensively studied, fungal microbiota is still poorly characterized. The analysis of induced sputum revealed that 90 fungal species were more abundant in asthmatics [99], of which members of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    genera Aspergillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and Penicillium were significantly associated with impaired post-bronchodilator expiratory volume in 1 s in asthmatics [100]. Severe asthmatics were characterized by enrichment of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Aspergillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
; the relative abundance of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Aspergillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 increased approximately 15-fold compared to mild asthmatics [101]. However, whether these organisms are cause or result of the pathophysiology or medications in asthma remains to be determined.</br> </br> As the main source of indoor air pollution, tobacco smoking, mostly in the form of cigarette smoking, is an important environmental factor influencing the outcomes of asthma. Smoking (including active and passive smoking) can not only cause frequent attacks of asthma, lead to rapid decline of lung function in asthmatic patients, but also reduce the therapeutic effect of glucocorticoid in asthmatic patients, making the condition of asthmatic patients difficult to control [102]. Microbial colonization of the lower airway may be shaped by smoking in asthma, accordingly, some of the increased risk and severity of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pulmonary disorders
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in tobacco smokers with asthma [103] could still be mediated through smoking-induced changes in the lung microbiome. Simpson et al. extracted DNA from induced sputum in asthma patients and profiled microbial communities using 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 rRNA pyrosequencing, the results showed ex-smokers have a higher prevalence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    phylum Fusobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, the phyla Firmicutes and Bacteroidetes, and a lower abundance of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 from 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    phylum Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 compared with never-smokers. They also revealed an association between smoking and increased diversity of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [104]. However, another study failed to demonstrate the association, because of no difference in bacterial dominance from induced sputum in asthma patients between ex-smokers and non-smokers, this lack of difference may be explained by the small sample size and different samples in that study [97]. More studies examining effect of smoking on airway microbiome in individuals with asthma are warranted.</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) is a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    multi-organ disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 with variable clinical characteristics, with pulmonary manifestations (e.g. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bronchiectasis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) being the prominent feature [105, 106]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Progressive lung disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 driven by microbial colonization and inflammation remains the leading cause of morbidity and mortality in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients [106]. The lung environment in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients, characterized by depletion of the airway surface liquid layer leading to impediment of mucociliary clearance, is ideal for microbial colonization [107]. Culture-independent molecular methods allowed emerging threads of the features of the respiratory microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 to be gradually discovered in recent years. The lung microbiota fluctuated in a chronological way and associated with clinical states. In 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients aged &lt; 2 years, nontraditional taxa (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    e.g. Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Prevotella and Veillonella) predominated, these species shifted to traditional 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 taxa (Pseudomonas, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Staphylococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Haemophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Stenotrophomonas and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Burkholderia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) [108] and remained relatively stable in older children (&gt; 6 years) and adults, especially in clinical stability [109–111]. With improvement of biological diagnosis, fungal and viral colonization in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 moved into the focus. Candida albicans and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Aspergillus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 fumigatus are commonly detected in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 sputum cultures and have also been associated with acute pulmonary exacerbations [112], and the number of fungal species detected in sputum fluctuated over time [113]. As for respiratory “virome” in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    precious
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 few data reported distinct phage communities in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 compared with non-
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients [114].</br> </br> Mutations of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 transmembrane conductance regulator (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CFTR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
), an epithelial anion channel, are predominant in the cause of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [115]. Smoking is one of the most important adverse factors affecting respiratory health. Recent researches pay close attention to the issue related to the impact of smoking in the pathology of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and clinical outcomes. Campbell et al. [116] found tobacco smoke in patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 exhibited poor clinical status, including reduced lung function, and a higher number of pulmonary-related hospitalizations. Some other studies focus on the variations of genes within the context of tobacco smoking and detected the associations between smoke exposure and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CTFR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 dysfunction [117, 118], which could in turn lead to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    deleterious
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 effects on airway surface liquid secretion, enhanced 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mucus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 expression, reduced mucociliary clearance, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic bacterial infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and excess inflammation [119], rendering the main morbidity and mortality in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients because of the fact that lung inflammation and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic respiratory infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 alone account for nearly 95% of the morbidity and mortality in patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [120]. In addition, smoking is known to stimulate mucosal linings and increase sputum production in the respiratory tract, raising the possibility of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacterial infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Yet, there is no evidence to investigate the microbiome (e.g. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients in the context of smoking. Both the effect of smoking on microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients and the possible causal relationship between smoking-induced variations of microbiome, possibly through 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CTFR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 dysfunction, and the clinical manifestations of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, could not be proved. We may assume the possible mechanism of detrimental effect of smoking on 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 may be because the alterations in microbiome due to airway surface liquid secretion, enhanced 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mucus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 expression, reduced mucociliary clearance induced by loss of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CTFR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 functions.</br> </br> Smoking and gut microbiome</br> The gastrointestinal microbiome is a complex echosystem of 10–100 trillion 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    microorganisms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 composed of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    virus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and fungal species, that develops immediately after birth depending on multiple factors, and fluctuates or changes resulted from affection of a number of factors such as age, drugs (especially antibiotics), diet, alcohol, and smoking throughout the whole time growing up [11, 17]. In virtue of the most extensively focus on microbiota colonizing the intestinal tract, it has become clear that in healthy individuals, the microbiome is inclined to remain rather stable, with Bacteroides, Faecalibacterium, and Bifidobacterium being the most 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    prevalent genera
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [121], and disturbance of the microbial equilibrium is associated with a variety of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    local and systemic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [17, 18].</br> </br> Smoking prevalence is the leading cause responsible for developing 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
), colonic carcinoma, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    systemic disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [122, 123]. The vulnerability of intestinal microbiome provokes interest in microbiome alterations in smoking environment. In animal models, cigarette smoke decreases organic acids levels and population of bifidobacterium in the caecum of rats [124]. Side-stream smoking increased the abundance of Clostridium and decreased the amount of Lactoccoci, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ruminococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, Enterobacteriaceae and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    segmented filamentous bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SFB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) in the cecal microflora [125]. In human studies, smoking increased the probability of developing 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Clostridium difficile infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [126]. Current smokers displayed increased Bacteroidetes and decreased Firmicutes and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in gut microbiota composition community compared with never smokers [127]. Another study also revealed healthy smokers harbour higher Bacteroides–Prevotella (34.8%) than nonsmokers (24.1%) [128]. In addition, smoking status is also connected with variations in gut microbiome, as reported by Biedermann et al. that healthy individuals undergoing smoking cessation increased Firmicutes and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Actinobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, while decreasing Bacteroidetes and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [129]. Many researchers investigated the role of smoking in gut microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, we will discuss the effects of smoking on gut microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    several diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
.</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) is a type of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 that mainly affect gastrointestinal tract, characterized by chronic inflammation due to defective mucosal barrier and greater intestinal permeability [130]. While the cause of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is multifactorial, a combination of environmental, immune, and bacterial factors in genetically susceptible individuals [131–133]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Microbial dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is thought to be associated with either development or exacerbation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    underlying Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [134]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients have a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    relevant dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of the gastrointestinal microbiome, including reduction of normal commensal phyla (Bacteroidetes and Firmicutes), increase of pathogenic organisms (E. coli, Campylobacter species, and Mycobacterium species) [135], and a greater number of mucosal 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    surface-associated bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 with higher adherence and invasion compared with healthy control subjects [136]. Researchers also found 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients possess a reduction in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Roseburia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp., Clostridium and Bacteroides species, known to be producers of butyrate, which is fundamental to intestinal cell homeostasis and mucosal barrier integrity [137, 138]. These studies have shed light on the possible causative role of the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of gut microbiota in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
.</br> </br> Smoking is the best studied environmental risk factor for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, exerting detrimental effects on mucosal barrier and greater intestinal permeability and disease susceptibility [139]. Accumulating data investigated the association between smoking and imbalance of intestinal microbiome [139]. Accordingly, several studies indicated that intestinal microbes could be an important link between smoking and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [139]. Benjamin et al. found greater abundance of Bacteroides–Prevotella in smoking patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 compared with nonsmokers through fluorescent in situ hybridization using probes targeting 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 rRNA of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [128]. In another study, Opstelten reported a reduced microbial gene richness and taxonomic diversity in smoking patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, they further demonstrated a statistically significant reduction in specific genera Collinsella, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Enterorhabdus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and Gordonibacter [140], which can produce urolithins with anti-inflammatory properties [141]. Faecalibacterium has immune-regulatory function to reduce IL-12 expression in peripheral blood mononuclear cell (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PBMC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) in vitro and increase IL-10 release, lower ileal mucosal Faecalibacterium prausnitzii is correlated with greater risk of recurrence following surgical resection in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients [142]. Murugananthan et al. revealed a reduction in the number of Faecalibacterium prausnitzii in inflamed mucosal tissue from smokers with active 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 compared with non-smokers, the risk of post-operative 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 recurrence may be predetermined at a pre-operative stage due to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. These observed features of reduced gut microbiota may explain the persistent intestinal inflammation in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients in smoky environment, highlighting the possible role of microbes interacting with smoking and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (or mediating the adverse effects of smoking in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
). However, the mechanisms through which smoking caused alterations in microbiota are unclear.</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) is another type of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic relapsing inflammatory disorder
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 confined to the colorectal region and to the mucosal layer of the gastrointestinal tract. Previous studies have demonstrated aberrant microbiota deviations from gut homeostasis in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients, as evidenced by a low taxonomic diversity, decreases in Firmicutes and increases in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Proteobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 gut microbiomes [143–145]. Proportions of Fusobacteriaceae family increased, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bifidobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and members of the Faecalibacterium taxon appeared to be compromised in gut microbiota of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients [146, 147], and further study suggested the reduced abundance of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bifidobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 as a microbial biomarker to identify the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    intestinal dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 triggering 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [147].</br> </br> The understanding of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and etiology of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is still out of reach. It was presumed that genetically susceptible individuals of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 or patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 exhibited aberrant mucosal immune response against their gut microbiota [148, 149], which could result in productions of pro-inflammatory cytokines responsible for abnormal inflammation reaction in the digestive tract [150]. Environmental factors were deemed to trigger the onset and cause flares of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Smoking is among the most widely studied factors described in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. The contradictory results of reverse associations between smoking and the natural history of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 has long been the topic of great interest. Some studies showed current smokers with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 are more likely to show 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    milder disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, fewer hospitalizations, and reduced need for corticosteroid and immunosuppressant therapy compared with non-smokers [151]. Others did not find the protective role [152, 153]. Li et al. [154] suggested cigarette smoking could change the composition of intestinal microbiota, modulate 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mucus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 production and inhibit repairing of the gastrointestinal tract. Nevertheless, the main components of cigarette smoking has inflammatory-regulatory properties, for instance, Heme oxygenase-1 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HO-1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) and carbon monoxide (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) play a role in modulating cytokine expression and macrophage bactericidal activity, regulating intestinal homeostasis and mucosal immune responses to the enteric microbiota [155, 156], both of which were involved in the possible pathological process in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. The exact mechanisms through which smoking is associated with alterations in microbiota are unclear. As yet, there is no data exploring the effect of smoking on gut microbiota in patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Smokers may have behavioral characteristics, such as diet, that predispose to a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    luminal and mucosal dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [157]. However, it is also possible that smoking has a direct influence on the microbiota, and this deserved to be mentioned in future research hotspots.</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) is considered a major public healthy issue, with approximately 700,000 deaths reported annually worldwide [158], ranking only second to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lung cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [159]. Chronic inflammation is a well-established factor associated with cancer onset, progression through mucosal disruption and the excess of reactive oxygen species (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ROS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) [160, 161]. At present, many scholars believe that the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 may be associated with the participation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    intestinal microorganisms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, which started the damage mechanisms of intestinal mucosal immune response, thus leading to immune response and inflammation [162]. The correlation between gut microbiome and the initiation of cancer can be dated from last century when people observed the potential etiology of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 bovis in the occurrence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [163]. In recent years, the disturbance of gut microbiome was further pushed to a high new climax, as distinct gut microbiome composition detected in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients.</br> </br> The abundance of several microbes, such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus gallolyticus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [164], Fusobacterium, [165], B. fragilis [166], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Escherichia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
–Shigella, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Peptostreptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 ten [167] were observed to be enriched in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    versus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 control groups, while 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    genera
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 such as Bacteroides, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Roseburia [164
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
] and Pseudomonas [167] were significantly depleted in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients. Moreover, the barely studied fields gut virome and mycobiome correlated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 were also reported when Nakatsu et al. identified a set of discriminatory virome signatures (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    e.g. Orthobunyavirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tunalikevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Phikzlikevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Betabaculovirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Sp6likevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Sfi21dtunalikevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Punalikevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lambdalikevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    C2likevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Mulikevirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) enriched in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 subjects [168], and when Coker et al. reported higher Malasseziomycetes and depleted Saccharomycetes and Pneumocystidomycetes in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients [169].</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    complex disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 susceptible to a variety of diet and lifestyle factors, especially smoking, a well-known factor involved in the initiation and increasing the risk of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 with a prolonged latency period [170]. Although the mechanisms of smoking-induced susceptibility to higher risk of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 remain to be elucidated, preliminary evidence suggests a collective role of host, microbial, and smoking, such as intestinal and immune disruption, impaired clearance of pathogens, changes in the virulence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and ingestion of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 that are present in cigarettes [171]. The fact as mentioned above that cigarette smoke or side-stream smoking decreases the amount of Bifidobacterium [124], mainly butyrate-producing 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 with anti-inflammatory and anti-tumor molecule role [172] was highly consistent with the results that 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    butyrate-producing bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 are depleted in cancer patients [170]. In addition, in vitro and in vivo studies found that cigarette smoke not only decrease the fecal abundance of Bifidobacterium but also reduce its production of short chain fatty acids (SCFAs) [124, 173], immune-regulatory molecules modulating immune and inflammatory response within 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    many diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and reductions in the concentration of SCFAs especially butyrate in colorectal tissues were demonstrated to be associated with the possibility of early stage 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 development [174]. Moreover, the smoking-related microbial changes may lead to altered epithelial mucin composition of the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mucus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 layer and increased inflammatory response [175], which play pivotal role in the onset of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CRC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
.</br> </br> Stated thus, these studies suggested that alterations of gut microbiome may be an essential contributing factor to the initiation and development of this cancer in the context of smoking.</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Systemic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> In addition to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of the gut microbiome has been implicated in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    many autoimmune diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, including 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    multiple sclerosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) [176], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rheumatoid arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) [177], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ankylosing spondylitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [178], 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    systemic lupus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    erythematous
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SLE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) [179], and [180]. Human studies and mouse models support the role of the gut microbiome in predisposition to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, such as reduction in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 belonging to the family Bifidobacterium and Bacteroides [181], and higher prevalence Prevotella copri [182]. Ye et al. also revealed higher abundance of Bilophila spp., and several opportunistic pathogens (e.g., Parabacteroides spp. and Paraprevotella spp.), together with a reduction in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    butyrate-producing bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Clostridium spp., and two 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    genera
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of methanogens (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Methanoculleus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp., 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Methanomethylophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 spp.) in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients [183]. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 has also been recently associated with changes of the intestinal microbiota with the study reporting depletion in species belonging to Clostridium and Bacteroidetes in Japanese patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [184].</br> </br> Smoking affects both innate and adaptive immune systems and plays dual roles in regulating immunity by either exacerbation of pathogenic immune responses or weakening of defensive immunity [185]. Smoking is a well-established risk factor for developing 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SLE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [186–189]. Epidemiologic data showed positive association between the incidence of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and smoking, the risk of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 increased with the number of pack-years of smoking increasing [190], smoking renders individuals with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HLA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
–
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DRB1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 shared epitope (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) alleles susceptible to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, stronger association existed in individuals carrying double copies of the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 [186]. The gut microbiome is responsible for maintaining homeostasis and function of host immune system indicating the probable essential role in changing the immune response that leads to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    autoimmune diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 like 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. As mentioned earlier, cigarette smoking could change the composition of intestinal microbiota [154], and some of the components play an important role in modulating intestinal homeostasis and immune responses to the enteric microbiota [155, 156]. The role of smoking involved in these diseases was assessed in both animal models and clinical trials, but so far no exact underlying mechanisms were identified. The gut microbiome may provide the missing link to this puzzle and help solve the mystery of the influence of smoking in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    autoimmune diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and this deserve the future research to further the understanding of the role of microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    systemic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
.</br> </br> Conclusions</br> In conclusion, microbiome research has enormously developed in the last years tempting to move its steps to better characterize the human microbiome. Smoking is the risk factor of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    several diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, it could impact human microbiome directly or indirectly through immunosuppression, oxygen deprivation, biofilm formation, or other potential mechanisms. None of the above mechanisms is well established, and adequate explanation of how smoking affects the microbiome is yet to be established. Microbiome has pivotal roles in the development of healthy immune responses, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oral, airway and gut microbial dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 can contribute to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    local or systemic various diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 such as 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 infection, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gastrointestinal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, asthma, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Evidence suggests the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    microbial dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    many diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in smoky environment, but the causal relationship between microbiome alterations and disease progress remains enigmatic. More basic and clinical researches may help us gain more insight into the hugely complex net-work of smoking–microbiome–host interactions underlying the observed associations. Longitudinal studies integrating metagenomic, transcriptomic, metabolomic, methods with clinical results may help us ascertain the relationships between smoking, microbiome, and pathological mechanism in diseases.</br> </br> Abbreviations</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPDchronic obstructive pulmonary diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> CScigarette smoke</br> </br> BALFbronchoalveolar lavage fluid</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CFcystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> CFTRcystic 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 transmembrane conductance regulator</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CDCrohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UCulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MSmultiple sclerosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RArheumatoid arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SLEsystemic lupus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    erythematous
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
</br> </br> Publisher's Note</br> </br> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</br> </br> Acknowledgements</br> None.</br> </br> Authors’ contributions</br> 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 wrote the review, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 revised the manuscript. Both authors read and approved the final manuscript.</br> </br> Funding</br> This study was supported by Grant 81770025 from National Natural Science Foundation of China, Grant 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ZH2018QNA48
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 from Cross research funds of Translational Medicine and Grant 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2017ZZ02014
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 from Shanghai key discipline for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    respiratory diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
.</br> </br> Availability of data and materials</br> Not applicable.</br> </br> Ethics approval and consent to participate</br> Not applicable.</br> </br> Consent for publication</br> Not applicable.</br> </br> Competing interests</br> The authors declare that they have no competing interests.</br> ==== Refs</br> References</br> 1. DeMarini 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Genotoxicity of tobacco smoke and tobacco smoke condensate: a review Mutat Res 2004 567 447 474 10.1016/j.mrrev.2004.02.001 15572290 </br> 2. Durazzo 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Mattsson N  Weiner 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Alzheimer’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 neuroimaging I: smoking and increased 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Alzheimer’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 risk: a review of potential mechanisms Alzheimers Dement 2014 10 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S122
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S145
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 10.1016/j.jalz.2014.04.009 24924665 </br> 3. Brook I  Gober 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Recovery of potential pathogens and interfering 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in the nasopharynx of smokers and nonsmokers Chest 2005 127 2072 2075 10.1378/chest.127.6.2072 15947322 </br> 4. Brook I  Gober 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Recovery of potential pathogens in the nasopharynx of healthy and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    otitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    media
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-prone children and their smoking and nonsmoking parents Ann Otol Rhinol Laryngol 2008 117 727 730 10.1177/000348940811701003 18998498 </br> 5. Shiloah J  Patters 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Waring 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The prevalence of pathogenic periodontal microflora in healthy young adult smokers J Periodontol 2000 71 562 567 10.1902/jop.2000.71.4.562 10807119 </br> 6. Correa P   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bacterial infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 as a cause of cancer J Natl Cancer Inst 2003 95 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    E3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 10.1093/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jnci/95.7.E3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 12671026 </br> 7. Hohenberger P  Gretschel S   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Gastric cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Lancet 2003 362 305 315 10.1016/S0140-6736(03)13975-X 12892963 </br> 8. Parsonnet J   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bacterial infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 as a cause of cancer Environ Health Perspect 1995 103 Suppl 8 263 268 10.1289/ehp.95103s8263 8741796 </br> 9. McKee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sussman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Case report: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    severe acute Parkinsonism
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 associated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    streptococcal infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and antibasal 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ganglia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 antibodies Mov Disord 2005 20 1661 1663 10.1002/mds.20641 16078204 </br> 10. Schulz JD  Hawkes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shaw 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cycad toxins, Helicobacter pylori  and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    parkinsonism
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: cholesterol glucosides as the common denomenator Med Hypotheses 2006 66 1222 1226 10.1016/j.mehy.2004.12.033 16488551 </br> 11. Gill 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Pop M  Deboy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Eckburg 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Turnbaugh 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Samuel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gordon 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JI
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Relman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fraser-Liggett 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nelson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Metagenomic analysis of the human distal gut microbiome Science 2006 312 1355 1359 10.1126/science.1124234 16741115 </br> 12. Human Microbiome Project C  Structure, function and diversity of the healthy human microbiome Nature 2012 486 207 214 10.1038/nature11234 22699609 </br> 13. Proctor 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The human microbiome project in 2011 and beyond Cell Host Microbe 2011 10 287 291 10.1016/j.chom.2011.10.001 22018227 </br> 14. Dy R  Sethi S   The lung microbiome and exacerbations of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Curr Opin Pulm Med 2016 22 196 202 10.1097/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MCP.0000000000000268
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 26964078 </br> 15. Huang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    YJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Charlson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ES
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Collman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Colombini-Hatch S  Martinez 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Senior 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report Am J Respir Crit Care Med 2013 187 1382 1387 10.1164/rccm.201303-0488WS 23614695 </br> 16. Kiley JP   Advancing respiratory research Chest 2011 140 497 501 10.1378/chest.11-0774 21813528 </br> 17. Faith JJ  Guruge 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Charbonneau M  Subramanian S  Seedorf H  Goodman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Clemente 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Knight R  Heath 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Leibel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    The long-term stability of the human gut microbiota Science 2013 341 1237439 10.1126/science.1237439 23828941 </br> 18. Owyang C  Wu 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The gut microbiome in health and disease Gastroenterology 2014 146 1433 1436 10.1053/j.gastro.2014.03.032 24675436 </br> 19. Humans IWGotEoCRt  Tobacco smoke and involuntary smoking 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IARC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Monogr Eval Carcinog Risks Hum 2004 83 1 1438 15285078 </br> 20. Bogden 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kemp 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Buse M  Thind 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Louria 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Forgacs J  Llanos G  Moncoya Terrones I   Composition of tobaccos from countries with high and low incidences of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lung cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. I. Selenium, polonium-210, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Alternaria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, tar, and nicotine J Natl Cancer Inst 1981 66 27 31 6935462 </br> 21. Eaton T  Falkinham 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 3rd  von Reyn 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Recovery of Mycobacterium avium  from cigarettes J Clin Microbiol 1995 33 2757 2758 8567919 </br> 22. Hasday 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bascom R  Costa 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fitzgerald T  Dubin W   Bacterial endotoxin is an active component of cigarette smoke Chest 1999 115 829 835 10.1378/chest.115.3.829 10084499 </br> 23. Kurup 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    VP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Resnick A  Kagen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cohen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fink 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Allergenic fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and actinomycetes in smoking materials and their health implications 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Mycopathologia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 1983 82 61 64 10.1007/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BF00436948
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 6348548 </br> 24. Larsson L  Szponar B  Ridha B  Pehrson C  Dutkiewicz J  Krysinska-Traczyk E  Sitkowska J   Identification of bacterial and fungal components in tobacco and tobacco smoke 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tob Induc Dis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2008 4 4 10.1186/1617-9625-4-4 18822161 </br> 25. Morishita Y   Mutagenicity of pyrolysates of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    salt-tolerant bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 from food and cigarettes Cancer Lett 1983 18 229 234 10.1016/0304-3835(83)90072-1 6831395 </br> 26. Pauly 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Waight 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Paszkiewicz 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Tobacco flakes on cigarette filters grow 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: a potential health risk to the smoker? Tob Control 2008 17 Suppl 1 i49 i52 10.1136/tc.2007.022772 18768459 </br> 27. Rooney 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Swezey 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wicklow 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  McAtee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Bacterial species diversity in cigarettes linked to an investigation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    severe pneumonitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in U.S. Military personnel deployed in operation Iraqi freedom Curr Microbiol 2005 51 46 52 10.1007/s00284-005-4491-z 15942700 </br> 28. Sapkota 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Berger S  Vogel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Human pathogens abundant in the bacterial metagenome of cigarettes Environ Health Perspect 2010 118 351 356 10.1289/ehp.0901201 20064769 </br> 29. Jaspers I   Cigarette smoke effects on innate immune mechanisms in the nasal mucosa. Potential effects on the microbiome Ann Am Thorac Soc 2014 11 Suppl 1 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S38
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S42
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 10.1513/AnnalsATS.201306-154MG 24437404 </br> 30. Mehta H  Nazzal K  Sadikot 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cigarette smoking and innate immunity Inflamm Res 2008 57 497 503 10.1007/s00011-008-8078-6 19109742 </br> 31. Arnson Y  Shoenfeld Y  Amital H   Effects of tobacco smoke on immunity, inflammation and autoimmunity J Autoimmun 2010 34 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    J258
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    J265
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 10.1016/j.jaut.2009.12.003 20042314 </br> 32. Matthews 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Milward 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ling 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chapple 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Neutrophil superoxide production in the presence of cigarette smoke extract, nicotine and cotinine J Clin Periodontol 2012 39 626 634 10.1111/j.1600-051X.2012.01894.x 22607095 </br> 33. Droemann D  Goldmann T  Tiedje T  Zabel P  Dalhoff K  Schaaf B   Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients Respir Res 2005 6 68 10.1186/1465-9921-6-68 16004610 </br> 34. Kulkarni R  Antala S  Wang A  Amaral 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Rampersaud R  Larussa 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Planet 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ratner 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cigarette smoke increases 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Staphylococcus aureus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  biofilm formation via oxidative stress Infect Immun 2012 80 3804 3811 10.1128/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IAI.00689
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-12 22890993 </br> 35. Mutepe 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ND
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cockeran R  Steel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Theron 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Mitchell 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Feldman C  Anderson R   Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin Eur Respir J 2013 41 392 395 10.1183/09031936.00213211 22743667 </br> 36. Oggioni 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Trappetti C  Kadioglu A  Cassone M  Iannelli F  Ricci S  Andrew 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Pozzi G   Switch from planktonic to sessile life: a major event in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pneumococcal pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Mol Microbiol 2006 61 1196 1210 10.1111/j.1365-2958.2006.05310.x 16925554 </br> 37. Mason 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Preshaw 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nagaraja HN  Dabdoub SM  Rahman A  Kumar 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The subgingival microbiome of clinically healthy current and never smokers 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ISME
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J 2015 9 268 272 10.1038/ismej.2014.114 25012901 </br> 38. Ganesan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Joshi V  Fellows M  Dabdoub 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nagaraja 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  O’Donnell B  Deshpande 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kumar 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   A tale of two risks: smoking, diabetes and the subgingival microbiome 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ISME
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J 2017 11 2075 2089 10.1038/ismej.2017.73 28534880 </br> 39. Shanahan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ER
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shah A  Koloski N  Walker 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Talley 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Morrison M  Holtmann 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Influence of cigarette smoking on the human duodenal mucosa-associated microbiota Microbiome 2018 6 150 10.1186/s40168-018-0531-3 30157953 </br> 40. Boral 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Studies on the erythropoietic effect of plasma from anemic toads both with and without testis Endokrinologie 1979 73 243 246 467379 </br> 41. Murthy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dinoso 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    VP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Jr  Clearfield 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chey 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Serial pH changes in the duodenal bulb during smoking Gastroenterology 1978 75 1 4 45574 </br> 42. Ainsworth 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hogan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Koss 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Isenberg 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JI
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cigarette smoking inhibits acid-stimulated duodenal mucosal bicarbonate secretion Ann Intern Med 1993 119 882 886 10.7326/0003-4819-119-9-199311010-00003 8214999 </br> 43. Warinner C  Rodrigues 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Vyas R  Trachsel C  Shved N  Grossmann J  Radini A  Hancock Y  Tito 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fiddyment S    Pathogens and host immunity in the ancient human oral cavity Nat Genet 2014 46 336 344 10.1038/ng.2906 24562188 </br> 44. Wade WG   The oral microbiome in health and disease Pharmacol Res 2013 69 137 143 10.1016/j.phrs.2012.11.006 23201354 </br> 45. Hayes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ahn J  Fan X  Peters 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ma Y  Yang L  Agalliu I  Burk 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ganly I  Purdue 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Association of oral microbiome with risk for incident head and neck 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    squamous cell cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JAMA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Oncol 2018 4 358 365 10.1001/jamaoncol.2017.4777 29327043 </br> 46. Fan X  Alekseyenko 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wu J  Peters 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Jacobs 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gapstur 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Purdue 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Abnet 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Stolzenberg-Solomon R  Miller G    Human oral microbiome and prospective risk for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pancreatic cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: a population-based nested case–control study Gut 2018 67 120 127 10.1136/gutjnl-2016-312580 27742762 </br> 47. Peters 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wu J  Pei Z  Yang L  Purdue 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Freedman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ND
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Jacobs 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gapstur 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hayes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ahn J   Oral microbiome composition reflects prospective risk for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    esophageal cancers
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Cancer Res 2017 77 6777 6787 10.1158/0008-5472.CAN-17-1296 29196415 </br> 48. Lonnroth I  Falsen E  Westin J  Lindholm L   Two cases of “
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    heavy chain disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
” Acta Pathol Microbiol Scand B Microbiol Immunol 1971 79 443 5283067 </br> 49. Macgregor 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ID
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Effects of smoking on oral ecology. A review of the literature Clin Prev Dent 1989 11 3 7 2689047 </br> 50. Nociti FH Jr  Casati 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MZ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Duarte 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Current perspective of the impact of smoking on the progression and treatment of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Periodontol 2000 2015 67 187 210 </br> 51. Colman G  Beighton D  Chalk 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wake S   Cigarette smoking and the microbial flora of the mouth Aust Dent J 1976 21 111 118 10.1111/j.1834-7819.1976.tb02833.x 1068665 </br> 52. Ertel A  Eng R  Smith 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The differential effect of cigarette smoke on the growth of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 found in humans Chest 1991 100 628 630 10.1378/chest.100.3.628 1889244 </br> 53. 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Morris
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 A  Beck 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Schloss 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Campbell 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Crothers K  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Curtis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Flores 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fontenot 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ghedin E  Huang L    Comparison of the respiratory microbiome in healthy nonsmokers and smokers Am J Respir Crit Care Med 2013 187 1067 1075 10.1164/rccm.201210-1913OC 23491408 </br> 54. Socransky 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Haffajee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Periodontal microbial ecology Periodontol 2000 2005 38 135 187 </br> 55. Tomar 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Asma S   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Smoking-attributable periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in the United States: findings from NHANES III. National Health and Nutrition Examination Survey J Periodontol 2000 71 743 751 10.1902/jop.2000.71.5.743 10872955 </br> 56. Johnson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hill M   Cigarette smoking and the periodontal patient J Periodontol 2004 75 196 209 10.1902/jop.2004.75.2.196 15068107 </br> 57. Hugoson A  Rolandsson M   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Periodontal disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983–2003) J Clin Periodontol 2011 38 809 816 10.1111/j.1600-051X.2011.01749.x 21762421 </br> 58. Shchipkova AY  Nagaraja HN  Kumar 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Subgingival microbial profiles of smokers with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J Dent Res 2010 89 1247 1253 10.1177/0022034510377203 20739702 </br> 59. Camelo-Castillo AJ  Mira A  Pico A  Nibali L  Henderson B  Donos N  Tomas I   Subgingival microbiota in health compared to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and the influence of smoking Front Microbiol 2015 6 119 10.3389/fmicb.2015.00119 25814980 </br> 60. Moon 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Subgingival microbiome in smokers and non-smokers in Korean 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chronic periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients Mol Oral Microbiol 2015 30 227 241 10.1111/omi.12086 25283067 </br> 61. Bizzarro S  Loos 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Laine 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ML
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Crielaard W  Zaura E   Subgingival microbiome in smokers and non-smokers in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: an exploratory study using traditional targeted techniques and a next-generation sequencing J Clin Periodontol 2013 40 483 492 10.1111/jcpe.12087 23489056 </br> 62. Duan X  Wu T  Xu X  Chen D  Mo A  Lei Y  Cheng L  Man Y  Zhou X  Wang Y  Yuan Q   Smoking may lead to marginal bone loss around non-submerged implants during bone healing by altering salivary microbiome: a prospective study J Periodontol 2017 88 1297 1308 10.1902/jop.2017.160808 28844190 </br> 63. Tsigarida 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dabdoub 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nagaraja 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kumar 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The influence of smoking on the peri-implant microbiome J Dent Res 2015 94 1202 1217 10.1177/0022034515590581 26124222 </br> 64. Lalla E  Papapanou 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Diabetes mellitus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: a tale of two 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    common interrelated diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Nat Rev Endocrinol 2011 7 738 748 10.1038/nrendo.2011.106 21709707 </br> 65. Beck 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Offenbacher S   Systemic effects of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: epidemiology of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    periodontal disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cardiovascular disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J Periodontol 2005 76 2089 2100 10.1902/jop.2005.76.11-S.2089 16277581 </br> 66. Deshpande 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Khan M  Genco 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Invasion strategies of the oral pathogen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    porphyromonas gingivalis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: implications for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cardiovascular disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Invasion Metastasis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 1998 18 57 69 10.1159/000024499 10364686 </br> 67. Parahitiyawa 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Jin LJ  Leung 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Yam 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Samaranayake 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Microbiology of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    odontogenic bacteremia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: beyond 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Clin Microbiol Rev 2009 22 46 64 10.1128/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CMR.00028
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-08 19136433 </br> 68. Verma D  Garg 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dubey 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Insights into the human oral microbiome Arch Microbiol 2018 200 525 540 10.1007/s00203-018-1505-3 29572583 </br> 69. Maraki S  Plevritaki A  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Kofteridis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 D  Scoulica E  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Eskitzis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 A  Gikas A  Panagiotakis 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bicuspid aortic valve endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 caused by Gemella sanguinis : case report and literature review J Infect Public Health 2019 12 304 308 10.1016/j.jiph.2019.01.001 30670353 </br> 70. Zhu B  Macleod 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kitten T  Xu P   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 sanguinis  biofilm formation &amp; interaction with oral pathogens Future Microbiol 2018 13 915 932 10.2217/fmb-2018-0043 29882414 </br> 71. Zbinden A  Aras F  Zbinden R  Mouttet F  Schmidlin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bloemberg 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bostanci N   Frequent detection of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus tigurinus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  in the human oral microbial flora by a specific 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16S
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 rRNA gene real-time TaqMan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PCR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BMC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Microbiol 2014 14 231 10.1186/s12866-014-0231-5 25170686 </br> 72. Matias 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bourque 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Niwano T  Onderdonk 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Katz 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Subacute bacterial Endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Leptotrichia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 goodfellowii  in a patient with a valvular allograft: a case report and review of the literature 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Case Rep Infect Dis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2016 2016 3051212 27895947 </br> 73. Moser C  Pedersen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lerche 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kolpen M  Line L  Thomsen K  Hoiby N  Jensen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Biofilms and host response—helpful or harmful 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    APMIS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2017 125 320 338 10.1111/apm.12674 28407429 </br> 74. Aas 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Barbuto 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Alpagot T  Olsen I  Dewhirst 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Paster 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Subgingival plaque microbiota in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 positive patients J Clin Periodontol 2007 34 189 195 10.1111/j.1600-051X.2006.01034.x 17309593 </br> 75. Mukherjee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chandra J  Retuerto M  Sikaroodi M  Brown 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Jurevic R  Salata 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lederman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gillevet 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ghannoum 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Oral mycobiome analysis of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-infected patients: identification of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Pichia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  as an antagonist of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    opportunistic fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 PLoS Pathog 2014 10 e1003996 10.1371/journal.ppat.1003996 24626467 </br> 76. Mukherjee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chandra J  Retuerto M  Tatsuoka C  Ghannoum 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  McComsey 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in the oral bacterial and fungal microbiome of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-infected subjects is associated with clinical and immunologic variables of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HIV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 infection PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2018 13 e0200285 10.1371/journal.pone.0200285 29995962 </br> 77. Kato I  Vasquez 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Moyerbrailean G  Land S  Sun J  Lin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ram 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Oral microbiome and history of smoking and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J Epidemiol Res 2016 2 92 101 10.5430/jer.v2n2p92 28111632 </br> 78. Hilty M  Burke C  Pedro H  Cardenas P  Bush A  Bossley C  Davies J  Ervine A  Poulter L  Pachter L    Disordered microbial communities in asthmatic airways PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2010 5 e8578 10.1371/journal.pone.0008578 20052417 </br> 79. Erb-Downward JR  Thompson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Han 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Freeman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  McCloskey L  Schmidt 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Young 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    VB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Toews 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Curtis 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sundaram B    Analysis of the lung microbiome in the “healthy” smoker and in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2011 6 e16384 10.1371/journal.pone.0016384 21364979 </br> 80. Mammen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sethi S   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and the microbiome Respirology 2016 21 590 599 10.1111/resp.12732 26852737 </br> 81. Pragman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kim 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Reilly 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wendt C  Isaacson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The lung microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    moderate and severe chronic obstructive pulmonary disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2012 7 e47305 10.1371/journal.pone.0047305 23071781 </br> 82. Millares L  Perez-Brocal V  Ferrari R  Gallego M  Pomares X  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Garcia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-Nunez M  Monton C  Capilla S  Monso E  Moya A   Functional metagenomics of the bronchial microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2015 10 e0144448 10.1371/journal.pone.0144448 26632844 </br> 83. Garmendia J  Morey P  Bengoechea 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Impact of cigarette smoke exposure on host–bacterial pathogen interactions Eur Respir J 2012 39 467 477 10.1183/09031936.00061911 21737564 </br> 84. Ko 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hui 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Goddard 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shaw 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Reid 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Yang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Acute exacerbation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    COPD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Respirology 2016 21 1152 1165 10.1111/resp.12780 27028990 </br> 85. Arcavi L  Benowitz 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cigarette smoking and infection Arch Intern Med 2004 164 2206 2216 10.1001/archinte.164.20.2206 15534156 </br> 86. Read 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Taylor 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The ecology of genetically 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    diverse infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Science 2001 292 1099 1102 10.1126/science.1059410 11352063 </br> 87. Klainer 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Beisel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Opportunistic infection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: a review Am J Med Sci 1969 258 431 456 10.1097/00000441-196912000-00007 4984755 </br> 88. Gregory 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sullivan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Segal 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Keller 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome Respir Res 2018 19 174 10.1186/s12931-018-0878-9 30208886 </br> 89. Thorburn 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  McKenzie 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CI
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shen S  Stanley D  Macia L  Mason 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Roberts 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wong 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shim R  Robert R    Evidence that asthma is a 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    developmental origin disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 influenced by maternal diet and bacterial metabolites Nat Commun 2015 6 7320 10.1038/ncomms8320 26102221 </br> 90. Fujimura 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sitarik 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Havstad S  Lin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Levan S  Fadrosh D  Panzer 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  LaMere B  Rackaityte E  Lukacs 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation Nat Med 2016 22 1187 1191 10.1038/nm.4176 27618652 </br> 91. Stokholm J  Blaser 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Thorsen J  Rasmussen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Waage J  Vinding 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Schoos 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kunoe A  Fink 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chawes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Maturation of the gut microbiome and risk of asthma in childhood Nat Commun 2018 9 141 10.1038/s41467-017-02573-2 29321519 </br> 92. Gollwitzer 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ES
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Saglani S  Trompette A  Yadava K  Sherburn R  McCoy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nicod 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lloyd 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Marsland 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Lung microbiota promotes tolerance to allergens in neonates via 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PD-L1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Nat Med 2014 20 642 647 10.1038/nm.3568 24813249 </br> 93. Turturice 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  McGee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Oliver B  Baraket M  Nguyen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ascoli C  Ranjan R  Rani A  Perkins 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Finn 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2017 12 e0184566 10.1371/journal.pone.0184566 29053714 </br> 94. Zhang Q  Cox M  Liang Z  Brinkmann F  Cardenas 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Duff R  Bhavsar P  Cookson W  Moffatt M  Chung 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Airway microbiota in severe asthma and relationship to asthma severity and phenotypes PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2016 11 e0152724 10.1371/journal.pone.0152724 27078029 </br> 95. Huang YJ  Nariya S  Harris 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lynch 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Choy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Arron 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Boushey H   The airway microbiome in patients with severe asthma: associations with disease features and severity J Allergy Clin Immunol 2015 136 874 884 10.1016/j.jaci.2015.05.044 26220531 </br> 96. Huang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    YJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nelson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Brodie 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Desantis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TZ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Baek 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Liu J  Woyke T  Allgaier M  Bristow J  Wiener-Kronish 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma J Allergy Clin Immunol 2011 127 372–381 e371 e373 </br> 97. Green 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wiriyachaiporn S  Grainge C  Rogers 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kehagia V  Lau L  Carroll 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bruce 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Howarth 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Potentially 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenic airway bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and neutrophilic inflammation in treatment resistant severe asthma PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2014 9 e100645 10.1371/journal.pone.0100645 24955983 </br> 98. Goleva E  Jackson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Harris 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Robertson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sutherland 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ER
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hall 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Good 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Jr  Gelfand 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Martin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Leung 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The effects of airway microbiome on corticosteroid responsiveness in asthma Am J Respir Crit Care Med 2013 188 1193 1201 10.1164/rccm.201304-0775OC 24024497 </br> 99. van Woerden HC  Gregory C  Brown R  Marchesi 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hoogendoorn B  Matthews 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BMC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Infect Dis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2013 13 69 10.1186/1471-2334-13-69 23384395 </br> 100. Agbetile J  Fairs A  Desai D  Hargadon B  Bourne M  Mutalithas K  Edwards R  Morley 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Monteiro 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kulkarni 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Isolation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    filamentous fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 from sputum in asthma is associated with reduced post-bronchodilator 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FEV1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Clin Exp Allergy 2012 42 782 791 10.1111/j.1365-2222.2012.03987.x 22515394 </br> 101. Chishimba L  Niven R  Fraczek M  Bowyer P  Smyth L  Simpson A  Denning D   Lung microbiome is associated with asthma severity in fungal associated asthma Eur Respir J 2015 46 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    OA1462
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 </br> 102. Thomson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chaudhuri R  Livingston E   Asthma and cigarette smoking Eur Respir J 2004 24 822 833 10.1183/09031936.04.00039004 15516679 </br> 103. Colak Y  Afzal S  Nordestgaard 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lange P   Characteristics and prognosis of never-smokers and smokers with asthma in the copenhagen general population study. A prospective cohort study Am J Respir Crit Care Med 2015 192 172 181 10.1164/rccm.201502-0302OC 25914942 </br> 104. Simpson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Daly J  Baines 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Yang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Upham 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Reynolds 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hodge S  James 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hugenholtz P  Willner D  Gibson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Airway dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Haemophilus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 influenzae  and Tropheryma  in poorly controlled asthma Eur Respir J 2016 47 792 800 10.1183/13993003.00405-2015 26647445 </br> 105. Lyczak 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cannon 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Pier 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Lung infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 associated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Clin Microbiol Rev 2002 15 194 222 10.1128/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CMR.15.2.194
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-222.2002 11932230 </br> 106. Gibson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Burns 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ramsey 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Pathophysiology and management of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pulmonary infections
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Am J Respir Crit Care Med 2003 168 918 951 10.1164/rccm.200304-505SO 14555458 </br> 107. Lynch 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bruce KD   The 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 airway microbiome Cold Spring Harb Perspect Med 2013 3 a009738 10.1101/cshperspect.a009738 23457293 </br> 108. Zemanick 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ET
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wagner 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Robertson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ahrens 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chmiel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Clancy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gibson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Harris 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kurland G  Laguna 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Airway microbiota across age and disease spectrum in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Eur Respir J 2017 50 1700832 10.1183/13993003.00832-2017 29146601 </br> 109. Mahenthiralingam E   Emerging 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 pathogens and the microbiome Paediatr Respir Rev 2014 15 Suppl 1 13 15 24832700 </br> 110. Fodor 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Klem 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ER
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gilpin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Elborn 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Boucher 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Tunney 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wolfgang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   The adult 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2012 7 e45001 10.1371/journal.pone.0045001 23049765 </br> 111. Blainey 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Milla 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cornfield 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Quake 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Sci Transl Med 2012 4 153ra130 10.1126/scitranslmed.3004458 23019655 </br> 112. Willger 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Grim 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dolben 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shipunova A  Hampton 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Morrison 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Filkins 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  O’Toole 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Moulton 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ashare A    Characterization and quantification of the fungal microbiome in serial samples from individuals with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Microbiome 2014 2 40 10.1186/2049-2618-2-40 25408892 </br> 113. Kramer R  Sauer-Heilborn A  Welte T  Guzman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Abraham 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hofle 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cohort study of airway mycobiome in adult 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients: differences in community structure between 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 reveal predominance of transient fungal elements J Clin Microbiol 2015 53 2900 2907 10.1128/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JCM.01094
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-15 26135861 </br> 114. Willner D  Furlan M  Haynes M  Schmieder R  Angly 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Silva J  Tammadoni S  Nosrat B  Conrad D  Rohwer F   Metagenomic analysis of respiratory tract DNA viral communities in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    non-cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 individuals PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2009 4 e7370 10.1371/journal.pone.0007370 19816605 </br> 115. Rowe 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Miller S  Sorscher 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 N Engl J Med 2005 352 1992 2001 10.1056/NEJMra043184 15888700 </br> 116. Campbell 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 3rd  Parker 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Roberts 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Krishnamani 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Phillips 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 3rd   Association of poor clinical status and heavy exposure to tobacco smoke in patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 who are 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    homozygous
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 for the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    F508
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 deletion J Pediatr 1992 120 261 264 10.1016/S0022-3476(05)80438-X 1735823 </br> 117. Collaco 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Vanscoy L  Bremer L  McDougal K  Blackman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bowers A  Naughton K  Jennings J  Ellen J  Cutting 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Interactions between secondhand smoke and genes that affect 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis lung disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JAMA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2008 299 417 424 10.1001/jama.299.4.417 18230779 </br> 118. Sloane PA  Shastry S  Wilhelm A  Courville C  Tang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Backer K  Levin E  Raju SV  Li Y  Mazur M    A pharmacologic approach to acquired 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 transmembrane conductance regulator dysfunction in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smoking related lung disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2012 7 e39809 10.1371/journal.pone.0039809 22768130 </br> 119. Amaral 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kunzelmann K   Molecular targeting of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CFTR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 as a therapeutic approach to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cystic fibrosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Trends Pharmacol Sci 2007 28 334 341 10.1016/j.tips.2007.05.004 17573123 </br> 120. Tyc VL  Throckmorton-Belzer L   Smoking rates and the state of smoking interventions for children and adolescents with chronic illness Pediatrics 2006 118 e471 e487 10.1542/peds.2004-2413 16882787 </br> 121. Robles Alonso V  Guarner F   Intestinal microbiota composition in adults World Rev Nutr Diet 2013 107 17 24 10.1159/000346875 </br> 122. Ananthakrishnan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Environmental risk factors for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gastroenterol Hepatol 2013 9 367 374 </br> 123. Persson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ahlbom A  Hellers G   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and tobacco smoke—a case–control study Gut 1990 31 1377 1381 10.1136/gut.31.12.1377 2265777 </br> 124. Tomoda K  Kubo K  Asahara T  Andoh A  Nomoto K  Nishii Y  Yamamoto Y  Yoshikawa M  Kimura H   Cigarette smoke decreases organic acids levels and population of bifidobacterium in the caecum of rats J Toxicol Sci 2011 36 261 266 10.2131/jts.36.261 21628954 </br> 125. Wang H  Zhao 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JX
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Hu N  Ren J  Du M  Zhu 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins World J Gastroenterol 2012 18 2180 2187 10.3748/wjg.v18.i18.2180 22611310 </br> 126. Rogers 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Greene 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Saint S  Chenoweth 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Malani 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Trivedi I  Aronoff 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Higher rates of Clostridium difficile  infection among smokers PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2012 7 e42091 10.1371/journal.pone.0042091 22848714 </br> 127. Lee SH  Yun Y  Kim SJ  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chang Y  Ryu S  Shin H  Kim 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kim 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study J Clin Med 2018 7 282 10.3390/jcm7090282 6162563 </br> 128. Benjamin JL  Hedin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Koutsoumpas A  Ng 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  McCarthy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Prescott 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Pessoa-Lopes P  Mathew 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sanderson J  Hart 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Smokers with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    active Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 have a clinically 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    relevant dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of the gastrointestinal microbiota 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Inflamm Bowel Dis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2012 18 1092 1100 10.1002/ibd.21864 22102318 </br> 129. Biedermann L  Zeitz J  Mwinyi J  Sutter-Minder E  Rehman A  Ott 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Steurer-Stey C  Frei A  Frei P  Scharl M    Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2013 8 e59260 10.1371/journal.pone.0059260 23516617 </br> 130. Baumgart 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sandborn 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Lancet 2012 380 1590 1605 10.1016/S0140-6736(12)60026-9 22914295 </br> 131. Stefanelli T  Malesci A  Repici A  Vetrano S  Danese S   New insights into 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 pathophysiology: paving the way for novel therapeutic targets Curr Drug Targets 2008 9 413 418 10.2174/138945008784221170 18473770 </br> 132. Cho 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Brant 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Recent insights into the genetics of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gastroenterology 2011 140 1704 1712 10.1053/j.gastro.2011.02.046 21530736 </br> 133. Dessein R  Chamaillard M  Danese S   Innate immunity in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: the reverse side of the medal J Clin Gastroenterol 2008 42 Suppl 3 Pt 1 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S144
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S147
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 10.1097/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MCG.0b013e3181662c90
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 18806708 </br> 134. Colombel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Decade in review-
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IBD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IBD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-genes, 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and new therapeutic strategies Nat Rev Gastroenterol Hepatol 2014 11 652 654 10.1038/nrgastro.2014.170 25311475 </br> 135. Chassaing B  Darfeuille-Michaud A   The commensal microbiota and enteropathogens in the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gastroenterology 2011 140 1720 1728 10.1053/j.gastro.2011.01.054 21530738 </br> 136. Swidsinski A  Loening-Baucke V  Herber A   Mucosal flora in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
—an overview J Physiol Pharmacol 2009 60 Suppl 6 61 71 20224153 </br> 137. Imhann F  Vich Vila A  Bonder 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fu J  Gevers D  Visschedijk 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Spekhorst 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Alberts R  Franke L  van Dullemen 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gut 2018 67 108 119 10.1136/gutjnl-2016-312135 27802154 </br> 138. Fava F  Danese S   Intestinal microbiota in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: friend of foe? World J Gastroenterol 2011 17 557 566 10.3748/wjg.v17.i5.557 21350704 </br> 139. Parkes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Whelan K  Lindsay 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Smoking in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: impact on disease course and insights into the aetiology of its effect 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    J Crohns Colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2014 8 717 725 10.1016/j.crohns.2014.02.002 24636140 </br> 140. Opstelten 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Plassais
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J  van Mil 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Achouri E  Pichaud M  Siersema 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Oldenburg B  Cervino 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Gut microbial diversity is reduced in smokers with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Inflamm Bowel Dis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2016 22 2070 2077 10.1097/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MIB.0000000000000875
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 27542127 </br> 141. Gonzalez-Sarrias A  Larrosa M  Tomas-Barberan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dolara P  Espin 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts Br J Nutr 2010 104 503 512 10.1017/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    S0007114510000826
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 20338073 </br> 142. Sokol H  Pigneur B  Watterlot L  Lakhdari O  Bermudez-Humaran 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gratadoux 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Blugeon S  Bridonneau C  Furet 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Corthier G    Faecalibacterium prausnitzii  is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Crohn disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients Proc Natl Acad Sci USA 2008 105 16731 16736 10.1073/pnas.0804812105 18936492 </br> 143. Huttenhower C  Kostic 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Xavier RJ   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 as a model for translating the microbiome Immunity 2014 40 843 854 10.1016/j.immuni.2014.05.013 24950204 </br> 144. Jacobs 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Goudarzi M  Singh N  Tong M  McHardy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ruegger P  Asadourian M  Moon 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ayson A  Borneman J    A disease-associated microbial and metabolomics state in relatives of pediatric 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients Cell Mol Gastroenterol Hepatol 2016 2 750 766 10.1016/j.jcmgh.2016.06.004 28174747 </br> 145. Sokol H  Seksik P   The intestinal microbiota in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: time to connect with the host Curr Opin Gastroenterol 2010 26 327 331 10.1097/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MOG.0b013e328339536b
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 20445446 </br> 146. Reshef L  Kovacs A  Ofer A  Yahav L  Maharshak N  Keren N  Konikoff 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Tulchinsky H  Gophna U  Dotan I   Pouch inflammation is associated with a decrease in specific bacterial taxa Gastroenterology 2015 149 718 727 10.1053/j.gastro.2015.05.041 26026389 </br> 147. Duranti S  Gaiani F  Mancabelli L  Milani C  Grandi A  Bolchi A  Santoni A  Lugli 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ferrario C  Mangifesta M    Elucidating the gut microbiome of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bifidobacteria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 as novel microbial biomarkers 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FEMS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Microbiol Ecol 2016 92 fiw191 10.1093/femsec/fiw191 27604252 </br> 148. de Souza 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fiocchi C   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Immunopathogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IBD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: current state of the art Nat Rev Gastroenterol Hepatol 2016 13 13 27 10.1038/nrgastro.2015.186 26627550 </br> 149. Rogler G  Vavricka S   Exposome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IBD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: recent insights in environmental factors that influence the onset and course of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IBD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Inflamm Bowel Dis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2015 21 400 408 10.1097/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MIB.0000000000000229
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 25358064 </br> 150. Singh 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Singh 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Murphy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Price 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Fayad R  Nagarkatti M  Nagarkatti 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Chemokine and cytokine levels in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients Cytokine 2016 77 44 49 10.1016/j.cyto.2015.10.008 26520877 </br> 151. Zhai H  Huang W  Liu A  Li Q  Hao Q  Ma L  Yang F  Zhang S   Current smoking improves ulcerative 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients’ disease behaviour in the northwest of China Prz Gastroenterol 2017 12 286 290 10.1007/s11377-017-0174-0 29358998 </br> 152. Wang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    YF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ou-Yang Q  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Xia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 B  Liu 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gu F  Zhou 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Mei Q  Shi 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ran 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ZH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    XD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Multicenter case–control study of the risk factors for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in China World J Gastroenterol 2013 19 1827 1833 10.3748/wjg.v19.i11.1827 23555172 </br> 153. Ng 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Tang W  Leong 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chen M  Ko Y  Studd C  Niewiadomski O  Bell S  Kamm 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  de Silva 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Environmental risk factors in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: a population-based case–control study in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Asia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
-Pacific Gut 2015 64 1063 1071 10.1136/gutjnl-2014-307410 25217388 </br> 154. Li 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lu L  Shen J  Zhang L  Wu 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wang L  Hu T  Li 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MX
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cho 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Cigarette smoking and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gastrointestinal diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: the causal relationship and underlying molecular mechanisms (review) Int J Mol Med 2014 34 372 380 10.3892/ijmm.2014.1786 24859303 </br> 155. Altarescu G  Rachmilewitz D  Zevin S   Relationship between 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CYP2A6
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    genetic polymorphism
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, as a marker of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nicotine metabolism
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Isr Med Assoc J 2011 13 87 90 21443033 </br> 156. Onyiah JC  Sheikh 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SZ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Maharshak N  Otterbein 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Plevy 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota Gut Microbes 2014 5 220 224 10.4161/gmic.27290 24637794 </br> 157. Dallongeville J  Marecaux N  Fruchart 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Amouyel P   Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis J Nutr 1998 128 1450 1457 10.1093/jn/128.9.1450 9732304 </br> 158. Torre LA  Bray F  Siegel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ferlay J  Lortet-Tieulent J  Jemal A   Global cancer statistics, 2012 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Cancer J Clin 2015 65 87 108 10.3322/caac.21262 25651787 </br> 159. Bray F  Ferlay J  Soerjomataram I  Siegel 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Torre LA  Jemal A   Global cancer statistics 2018: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GLOBOCAN
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 estimates of incidence and mortality worldwide for 36 cancers in 185 countries 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Cancer J Clin 2018 68 394 424 10.3322/caac.21492 30207593 </br> 160. Rogler G   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Chronic ulcerative colitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Cancer Lett 2014 345 235 241 10.1016/j.canlet.2013.07.032 23941831 </br> 161. Hanahan D  Weinberg 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Hallmarks of cancer: the next generation Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230 </br> 162. Saus E  Iraola-Guzman S  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Willis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Brunet-Vega A  Gabaldon T   Microbiome and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: Roles in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    carcinogenesis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and clinical potential Mol Aspects Med 2019 10.1016/j.mam.2019.05.001 31082399 </br> 163. Hoppes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lerner 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PI
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Nonenterococcal 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    group-D streptococcal endocarditis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 caused by 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Streptococcus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 bovis  Ann Intern Med 1974 81 588 593 10.7326/0003-4819-81-5-588 4422602 </br> 164. Wang T  Cai G  Qiu Y  Fei N  Zhang M  Pang X  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Jia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 W  Cai S  Zhao L   Structural segregation of gut microbiota between 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients and healthy volunteers 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ISME
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J 2012 6 320 329 10.1038/ismej.2011.109 21850056 </br> 165. Feng Q  Liang S  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Jia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 H  Stadlmayr A  Tang L  Lan Z  Zhang D  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Xia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 H  Xu X  Jie Z    Gut microbiome development along the colorectal adenoma–carcinoma sequence Nat Commun 2015 6 6528 10.1038/ncomms7528 25758642 </br> 166. Yu J  Feng Q  Wong 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Zhang D  Liang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    QY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Qin Y  Tang L  Zhao H  Stenvang J  Li Y    Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gut 2017 66 70 78 10.1136/gutjnl-2015-309800 26408641 
 167. Gao Z  Guo B  Gao R  Zhu Q  Qin H   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Microbiota disbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 is associated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Front Microbiol 2015 6 20 25699023 </br> 168. Nakatsu G  Zhou H  Wu WKK  Wong 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Coker 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    OO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dai Z  Li X  Szeto 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sugimura N  Lam 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Alterations in enteric virome are associated with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and survival outcomes Gastroenterology 2018 155 529–541 e525 </br> 169. Coker 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    OO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nakatsu G  Dai 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RZ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wu 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    WKK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wong 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ng 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FKL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sung 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JJY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Yu J   Enteric 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fungal microbiota dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and ecological alterations in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gut 2019 68 654 662 10.1136/gutjnl-2018-317178 30472682 </br> 170. Song M  Chan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AT
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Environmental factors, gut microbiota, and colorectal cancer prevention Clin Gastroenterol Hepatol 2019 17 275 289 10.1016/j.cgh.2018.07.012 30031175 </br> 171. Budden 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gellatly 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Wood 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cooper 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Morrison M  Hugenholtz P  Hansbro 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Emerging pathogenic links between microbiota and the gut–lung axis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Nat Rev Microbiol 2017 15 55 63 10.1038/nrmicro.2016.142 27694885 </br> 172. Bozkurt 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Quigley 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Kara B   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Bifidobacterium animalis subspecies lactis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 engineered to produce mycosporin-like amino acids in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    colorectal cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 prevention 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SAGE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Open Med 2019 7 2050312119825784 10.1177/2050312119825784 30719295 </br> 173. Hu J  Wei T  Sun S  Zhao A  Xu C   Effects of cigarette smoke condensate on the production and characterization of exopolysaccharides by Bifidobacterium  An Acad Bras Cienc 2015 87 997 1005 10.1590/0001-3765201520140518 26062117 </br> 174. Kurata N  Tokashiki N  Fukushima K  Misao T  Hasuoka N  Kitagawa K  Mashimo M  Regan JW  Murayama T  Fujino H   Short chain fatty acid butyrate uptake reduces expressions of prostanoid 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EP4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 receptors and their mediation of cyclooxygenase-2 induction in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HCA-7
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    human colon cancer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 cells Eur J Pharmacol 2019 853 308 315 10.1016/j.ejphar.2019.04.014 30980797 </br> 175. Allais L  Kerckhof 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Verschuere S  Bracke 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KR
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  De Smet R  Laukens D  Van den Abbeele P  De Vos M  Boon N  Brusselle 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    GG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut Environ Microbiol 2016 18 1352 1363 10.1111/1462-2920.12934 26033517 </br> 176. Berer K  Gerdes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cekanaviciute E  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Jia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 X  Xiao L  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Xia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Z  Liu C  Klotz L  Stauffer U  Baranzini 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Gut microbiota from 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    multiple sclerosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 patients enables 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    spontaneous autoimmune encephalomyelitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in mice Proc Natl Acad Sci USA 2017 114 10719 10724 10.1073/pnas.1711233114 28893994 </br> 177. Zhang X  Zhang D  
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Jia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 H  Feng Q  Wang D  Liang D  Wu X  Li J  Tang L  Li Y    The oral and gut microbiomes are perturbed in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rheumatoid arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and partly normalized after treatment Nat Med 2015 21 895 905 10.1038/nm.3914 26214836 </br> 178. Wen C  Zheng Z  Shao T  Liu L  Xie Z  Le Chatelier E  He Z  Zhong W  Fan Y  Zhang L    Quantitative metagenomics reveals unique gut microbiome biomarkers in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ankylosing spondylitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Genome Biol 2017 18 142 10.1186/s13059-017-1271-6 28750650 </br> 179. He Z  Shao T  Li H  Xie Z  Wen C   Alterations of the gut microbiome in Chinese patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    systemic lupus erythematosus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gut Pathog 2016 8 64 10.1186/s13099-016-0146-9 27980687 </br> 180. Morgan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    XC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Tickle 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Sokol H  Gevers D  Devaney 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ward 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Reyes 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Shah 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  LeLeiko N  Snapper 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Dysfunction of the intestinal microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory bowel disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 and treatment Genome Biol 2012 13 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    R79
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 10.1186/gb-2012-13-9-r79 23013615 </br> 181. Vaahtovuo J  Munukka E  Korkeamaki M  Luukkainen R  Toivanen P   Fecal microbiota in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    early rheumatoid arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J Rheumatol 2008 35 1500 1505 18528968 </br> 182. Bernard NJ   
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Rheumatoid arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: Prevotella copri  associated with new-onset untreated 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Nat Rev Rheumatol 2014 10 2 10.1038/nrrheum.2013.187 24275964 </br> 183. Ye Z  Zhang N  Wu C  Zhang X  Wang Q  Huang X  Du L  Cao Q  Tang J  Zhou C    A metagenomic study of the gut microbiome in 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Behcet’s disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Microbiome 2018 6 135 10.1186/s40168-018-0520-6 30077182 </br> 184. Miyake S  Kim S  Suda W  Oshima K  Nakamura M  Matsuoka T  Chihara N  Tomita A  Sato W  Kim 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Dysbiosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 in the gut microbiota of patients with 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    multiple sclerosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
, with a striking depletion of species belonging to 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Clostridia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  XIVa and 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IV
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 clusters PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2015 10 e0137429 10.1371/journal.pone.0137429 26367776 </br> 185. Klareskog L  Padyukov L  Alfredsson L   Smoking as a trigger for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inflammatory rheumatic diseases
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Curr Opin Rheumatol 2007 19 49 54 10.1097/
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BOR.0b013e32801127c8
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 17143096 </br> 186. Bang 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SY
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KH
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Cho 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Lee 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KW
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Bae 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Smoking increases 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rheumatoid arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 susceptibility in individuals carrying the 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HLA-DRB1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Arthritis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Rheum 2010 62 369 377 20112396 </br> 187. Ludvigsson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    JF
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Nordenvall C  Jarvholm B   Smoking, use of moist snuff and risk of 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    celiac disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: a prospective study 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BMC
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Gastroenterol 2014 14 120 10.1186/1471-230X-14-120 24994113 </br> 188. Kaan U  Ferda O   Evaluation of clinical activity and functional impairment in smokers with ankylosing 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    spondylitis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 Rheumatol Int 2005 25 357 360 10.1007/s00296-004-0451-3 14991231 </br> 189. Simon KC  Munger KL  Ascherio A   XVI European Charcot Foundation lecture: nutrition and environment: can 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 be prevented? J Neurol Sci 2011 311 1 8 10.1016/j.jns.2011.09.009 21975017 </br> 190. Ascherio A  Munger KL   Environmental risk factors for 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    multiple sclerosis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
. Part 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    II
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
: 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    noninfectious
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 factors Ann Neurol 2007 61 504 513 10.1002/ana.21141 17492755 </br> 191. Wu J  Peters 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dominianni C  Zhang Y  Pei Z  Yang L  Ma Y  Purdue 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    MP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Jacobs 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    EJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Gapstur 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    SM
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
    Cigarette smoking and the oral microbiome in a large study of American adults 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ISME
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 J 2016 10 2435 2446 10.1038/ismej.2016.37 27015003 </br> 192. Valles Y  Inman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    CK
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Peters 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Ali R  Wareth 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    LA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Abdulle A  Alsafar H  Anouti 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Dhaheri 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    AA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Galani D    Types of tobacco consumption and the oral microbiome in the United Arab Emirates Healthy Future (
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    UAEHFS
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
) Pilot Study Sci Rep 2018 8 11327 10.1038/s41598-018-29730-x 30054546 </br> 193. Charlson 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ES
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Chen J  Custers-Allen R  Bittinger K  Li H  Sinha R  Hwang J  Bushman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    FD
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Collman 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    RG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
   Disordered microbial communities in the upper respiratory tract of cigarette smokers PLoS 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ONE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
 2010 5 e15216 10.1371/journal.pone.0015216 21188149 </br> 194. Zhang R  Chen L  Cao L  Li 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    KJ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Huang Y  Luan 
<mark class="entity" style="background: #909090; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    XQ
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DIS</span>
</mark>
  Li G   Effects of smoking on the lower respiratory tract microbiome in mice Respir Res 2018 19 253 10.1186/s12931-018-0959-9 30547792</br> </br></div>
</figure>
</body>
</html>